Skip to main content
Premium Trial:

Request an Annual Quote

Jack Dixon, George Palade, Julia Ronde, Peter Zagorin, James Yee, Robert Neumeister Jr.


Jack Dixon will become dean for scientific affairs and health sciences at the University of California, San Diego, in February, following George Palade, who retired about a year ago. Dixon currently directs the life sciences institute at the University of Michigan. In California, he will also hold faculty appointments as professor of pharmacology and of cellular and molecular medicine. Dixon is known for his work on signal transduction, especially phosphatases and their role in cancer as well as in the cellular response to bacterial toxins. He has a BA from UCLA and a PhD from UC Santa Barbara, and conducted postdoctoral research at UCSD.


Julia Ronde has joined Oxford GlycoSciences as head of human resources. Most recently, she was vice president for human resources at Parexel International.

Peter Zagorin has become vice president for marketing at OGS, joining the company from the US pharmaceutical division of Bayer, where he was deputy director for anti-infective marketing. Besides product marketing, he will be responsible for corporate communications.


James Yee has been appointed head of development at Celera Genomics. He will be responsible for building the development organization at Celera South San Francisco and for leading therapeutic development and clinical trials at Celera. Yee joins the company from Roche Bioscience, where he was vice president for clinical and preclinical research for the inflammatory and viral diseases unit. Prior to that, he held a variety of research and development positions at Syntex and Roche Pharmaceuticals.


Robert Neumeister Jr. has left Myriad Proteomics, where he was CFO, to become executive vice president and CFO of directory company Dex Media East. He holds an MBA from the University of Virginia’s Colgate Darden Graduate School of Business and a bachelor’s degree in Economics and English from Vanderbilt University.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.